Cancers, Vol. 15, Pages 2144: Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification

Cancers, Vol. 15, Pages 2144: Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification Cancers doi: 10.3390/cancers15072144 Authors: Jyotirmayee Talapatra Mamatha M. Reddy Tumor cells reprogram their metabolism, including glucose, glutamine, nucleotide, lipid, and amino acids to meet their enhanced energy demands, redox balance, and requirement of biosynthetic substrates for uncontrolled cell proliferation. Altered lipid metabolism in cancer provides lipids for rapid membrane biogenesis, generates the energy required for unrestricted cell proliferation, and some of the lipids act as signaling pathway mediators. In this review, we focus on the role of lipid metabolism in embryonal neoplasms with MYCN dysregulation. We specifically review lipid metabolic reactions in neuroblastoma, retinoblastoma, medulloblastoma, Wilms tumor, and rhabdomyosarcoma and the possibility of targeting lipid metabolism. Additionally, the regulation of lipid metabolism by the MYCN oncogene is discussed.
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research